ClinicalTrials.gg
Active, not recruitingNCT07008937BalneotherapyUpdated Nov 9, 2026

The Effect of Balneotherapy on Knee Osteoarthritis

An interventional study of Balneotherapy and home exercise program in Osteoarthritis of Knee, sponsored by Ahi Evran University Education and Research Hospital. Active, not recruiting at 1 site in Turkey (Türkiye). Open to participants aged 50 Years and older. Per ClinicalTrials.gov, last updated 2026-11-09.

Sponsored by Ahi Evran University Education and Research Hospital · Not applicable, Interventional, and Treatment

How we know

Updated Nov 9, 2026Now Active, not recruitingFirst site in Turkey (Türkiye)+6 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
50 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 268 studies in Osteoarthritis, Knee with a site in Turkey — 52 open to participants now, 63 under way, 3 of them phase 3. Osteoarthritis, Knee · Turkey.

Enrollment
125th of 198
50 · median 60
Started
2025
with 46 others
No phase
189 of 268
30 open now
Primary completion
2026-07
later than 21 of 62 live
Registered
185th of 268
by date

Among the 268 studies in Osteoarthritis, Knee with a site in Turkey, this one is the 125th largest by enrollment of the 198 interventional ones that give a count, is one of 47 that started in 2025, is one of 189 with no phase, reaches primary completion later than 21 of the 62 other live ones, and was the 185th registered.

Osteoarthritis, Knee

3,297 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.

Browse Osteoarthritis, Knee studies →

Open to participants now

52 of the 268 studies in Osteoarthritis, Knee with a site in Turkey are open now. Recruiting first, the newest first:

47 more — sign in →

All 52 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 384 Osteoarthritis, Knee studies recruiting now, 178 (46%) set no upper age limit and 113 (29%) stop at 75 or younger; 19 take children under 18; 39 take healthy volunteers.

This study: 50 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 268 studies in Osteoarthritis, Knee with a site in Turkey, or all of them as a file.
02

Study summary

Osteoarthritis (OA) is a chronic degenerative disease characterized by the breakdown and repair processes of the cartilage structure in synovial joints. Balneotherapy is one of the most commonly applied treatment methods in patients with OA. It is used to reduce pain and stiffness, improve joint mobility and quality of life, and prevent disease progression. Hyperthermia caused by balneotherapy activates the sympathetic nervous system and the hypothalamic-pituitary-adrenal (HPA) axis. After heat stress, HSp levels in the blood increase, triggering the HSp-cytokine-HPA-cortisol anti-inflammatory feedback mechanism, resulting in an anti-inflammatory effect and neuroendocrine immune regulation.

In various pathologies associated with low-grade inflammation-especially rheumatic diseases-balneotherapy and mud therapy have been reported to decrease serum concentrations of pro-inflammatory cytokines such as TNF-α and IL-1β. Serum COMP levels are elevated in OA patients. There is evidence that measuring COMP levels could serve as a prognostic marker for the development of OA in patients with chronic knee pain. It is evaluated not only as a cartilage marker but also as an indicator of synovial inflammation.

The aim of this study is to evaluate the response to inflammation and stress in patients with knee OA by examining the levels of CRP, IL-1 beta, COMP, and HSp following balneotherapy treatment. Additionally, changes in patients' quality of life and functional status after balneotherapy will also be evaluated.Fifty patients with primary osteoarthritis who meet the inclusion criteria and are receiving inpatient or outpatient treatment in the Physical Medicine and Rehabilitation clinic will be included in the study. It is planned to include 30 patients in the treatment group and 20 patients in the control group. Pain will be assessed using VAS, physical function and stiffness using WOMAC, and quality of life using the SF-36 scale. To determine the serum levels of COMP, IL-1 beta, CRP, and HSp70, blood samples will be collected under standard conditions from patients in a fasting state between 8:00-9:00 AM. Biochemical markers will be evaluated using ELISA kits.

For balneotherapy, patients will be treated in a thermal pool for 15-20 minutes daily, with full-body immersion, for a total of 15 days.

Read the detailed description

In various pathologies associated with low-grade inflammation-especially rheumatic diseases-balneotherapy and mud therapy have been reported to decrease serum concentrations of pro-inflammatory cytokines such as TNF-α and IL-1β. COMP (cartilage oligomeric matrix protein) contributes to the stabilization of the collagen network by binding to collagen IX. Serum COMP levels are elevated in OA patients. There is evidence that measuring COMP levels could serve as a prognostic marker for the development of OA in patients with chronic knee pain. In OA, elevated IL-1 levels increase matrix metalloproteinase (MMP) levels and reduce TIMP synthesis. IL-1 plays the major role in the production of destructive enzymes. It also increases the synthesis of PGE2, which promotes inflammation and bone resorption. While severe heat stress causes cellular damage and cell death, the mild heat stress seen in balneotherapy induces a heat shock response. Following stress stimuli such as heat and inflammation, intracellular synthesis of heat shock proteins (HSp) increases, and there is a significant transition to the extracellular space. After heat stress, HSp levels in the blood increase, triggering the HSp-cytokine-HPA-cortisol anti-inflammatory feedback mechanism.

To investigate the effect of balneotherapy on these markers; Male and female patients aged between 50 and 80 years with knee osteoarthritis (KOA) at stages 2 to 4 according to the Kellgren-Lawrence classification (Kellgren and Lawrence, 1957), based on imaging performed within the past year, were included in the study. The study is a parallel-group randomized controlled trial conducted at the Thermal Center of Kırşehir Ahi Evran Training and Research Hospital. The RCT was approved by the Ethics Committee of Kırşehir Ahi Evran University; The study is planned to start in July 2025 and to be completed in November 2025. Participants will be randomly assigned to the intervention and control groups in a 1:1 allocation ratio.

The intervention group is planned to receive therapy 5 days a week, at the same time each morning, for 15-20 minutes per session, totaling 15 sessions. The control group will receive a home exercise program and simple analgesic treatment such as paracetamol. Both control and intervention groups received a booklet with general information and advice about how to improve the symptoms and progression of knee osteoarthritis. Data will be expressed as mean ± SD. Statistical analyses will be performed using SPSS version 22. A p-value of \<0.05 will be considered statistically significant. Wilcoxon test will be used for comparisons before and after treatment, and Mann-Whitney U test will be used for comparisons between groups.

03

Conditions studied

  • Osteoarthritis of Knee
04

Who can participate

Ages eligible
50 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being over 50 years old
  • Patients diagnosed with knee OA
  • At stages 2-to-4 according to the Kellgren- Lawrence classification
  • Patients who agree to receive balneotherapy treatment

Exclusion criteria

Exclusion Criteria:

  • Neoplasia
  • Infections
  • Uncompensated cardiac or pulmonary problems
  • Total knee arthroplasty
  • Inflammatory joint diseases (e.g., RA, AS)
  • Intra-articular injections in the past 6 months
  • or anti-cytokine therapy
  • Patients with a over 30 kg/m2
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
50 participants (actual)

Study arms

  • Experimental
    Balneotherapy group (group 1)

    Group 1 -Patients in the research group will receive geothermal treatment (spa therapy) for 20 minutes daily for 15 days.

    Other: Balneotherapy

  • Other
    Control Group (group 2)

    Group 2- Patients in the control group will be followed up with only a home exercise program

    Other: home exercise program

Interventions

  • OtherBalneotherapy

    For balneotherapy, patients will be treated in a thermal pool for 15-20 minutes daily, with full-body immersion, for a total of 15 days. For control, Volunteers in the control group will only receive a home exercise program. They will be called in for a check-up every five days to confirm that the home program is being followed correctly. In this way, the volunteers in the control group will not be left completely without treatment.

  • Otherhome exercise program

    home exercise program

06

What researchers measure

Primary outcomes

  1. the serum levels of COMP

    Before starting the treatment and one day after completing the 15-session balneotherapy, levels of COMP, will be measured in the intervention group.

    Time frame: It will be measured one day before the start of the balneotherapy (baseline) and one day after completing the 15-session therapy (15 days).

  2. the serum levels of IL-1 Beta

    Before starting the treatment and one day after completing the 15-session balneotherapy, IL-1 beta will be measured in the intervention group.

    Time frame: It will be measured one day before the start of the balneotherapy (baseline) and one day after completing the 15-session therapy (15 days)

  3. the serum levels of HSp70

    Before starting the treatment and one day after completing the 15-session balneotherapy, levels of HSp70 will be measured in the intervention group.

    Time frame: It will be measured one day before the start of the balneotherapy (baseline) and one day after completing the 15-session therapy (15 days)

  4. the serum levels of CRP

    Before starting the treatment and one day after completing the 15-session balneotherapy, CRP will be measured in the intervention group.

    Time frame: It will be measured one day before the start of the balneotherapy (baseline) and one day after completing the 15-session therapy

Secondary outcomes

  1. Pain intensity assessed by Visual Analog Scale (VAS)

    The Visual Analogue Scale (VAS) measures pain intensity. The VAS consists of a 10cm line, with two end points representing 0 ('no pain') and 10 ('pain as bad as it could possibly be').

    Time frame: Assessments will be made at baseline and at the end of treatment (15 season ) completion (15 days) for both groups.

  2. Functional status assessed by Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)

    The WOMAC measures five items for pain (score range 0-20), two for stiffness (score range 0-8), and 17 for functional limitation (score range 0-68). Higher scores indicate worse pain, stiffness, and functional limitations.

    Time frame: Assessments will be made at baseline and at the end of treatment (15 season ) completion (15 days) for both groups.

  3. Health-related quality of life assessed by Short Form-36 (SF-36)

    The SF-36 is used to objective measure of the quality of life.It comprises 36 questions that cover eight domains of health. Higher scores indicate better health status.

    Time frame: Assessments will be made at baseline and at the end of treatment (15 season ) completion (15 days) for both groups.

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Nov 2025 to primary completion in Jul 2026, 8 months.

Of 1,114 non-industry interventional studies with no phase under Osteoarthritis, Knee, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's 8 months is below that.

Counting every sponsor, half of 1,253 studies reached it within 18 months; a quarter within 8 and three quarters within 36.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 9, 2026: start Jul 2025 → Nov 2025, primary completion Nov 2025 → Jul 2026 and completion Dec 2025 → Nov 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
May 23, 2025
First posted
Jun 6, 2025
StartActual
Nov 1, 2025was Jul 2025
Primary completionActual
Jul 1, 2026was Nov 2025
CompletionEst.
Nov 30, 2026was Dec 2025
Last update
Nov 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Active, not recruiting
changed Nov 9, 2026
Sites
1 site added — first site in Turkey (Türkiye)
Show site
  • Kırşehir Ahi Evran University Faculty of Medicine · Kırşehir, Turkey (Türkiye)
Nov 9, 2026
Start date
Jul 2025→Nov 1, 2025 (actual)
Nov 9, 2026
Primary completion
Nov 2025→Jul 1, 2026 (actual)
Nov 9, 2026
Study completion
Dec 2025→Nov 30, 2026
Nov 9, 2026
Primary outcomes
1 edited, 3 added
What changed in the outcomes
  • Editedthe serum levels of COMP, IL-1 beta, CRP, and HSp70Time frame: Levels of COMP, IL-1 beta, CRP, and HSp70 will be measured one day before the start of the balneotherapy (baseline) and one day after completing the 15-session therapy (15 days) → It will be measured one day before the start of the balneotherapy (baseline) and one day after completing the 15-session therapy (15 days).
  • Addedthe serum levels of IL-1 BetaTime frame: It will be measured one day before the start of the balneotherapy (baseline) and one day after completing the 15-session therapy (15 days)
  • Addedthe serum levels of HSp70Time frame: It will be measured one day before the start of the balneotherapy (baseline) and one day after completing the 15-session therapy (15 days)
  • Addedthe serum levels of CRPTime frame: It will be measured one day before the start of the balneotherapy (baseline) and one day after completing the 15-session therapy
Nov 9, 2026
Secondary outcomes
3 edited
What changed in the outcomes
  • EditedFunctional status assessed by Western Ontario veand McMaster Universities OsteoartritOsteoarthritis Index (WOMAC)Time frame: Assessments will be made at baseline and at the end of treatment (15 season ) completion (15 days) for both groups.
  • ChangedBefore Visual Analogue ScaleNow Pain intensity assessed by Visual Analog Scale (VAS)Time frame: Assessments will be made at baseline and at the end of treatment (15 season ) completion (15 days) for both groups.
  • ChangedBefore Short -Form 36Now Health-related quality of life assessed by Short Form-36 (SF-36)Time frame: Assessments will be made at baseline and at the end of treatment (15 season ) completion (15 days) for both groups.
Nov 9, 2026
Show all 1 update
  1. Nov 9, 2026
    Not yet recruiting→Active, not recruiting
    1 site added — first site in Turkey (Türkiye)
    Show site
    • Kırşehir Ahi Evran University Faculty of Medicine · Kırşehir, Turkey (Türkiye)
    Start date Jul 2025→Nov 1, 2025 (now actual)
    Primary completion Nov 2025→Jul 1, 2026 (now actual)
    Study completion Dec 2025→Nov 30, 2026
    Primary outcomes 1 edited, 3 added
    What changed in the outcomes
    • Editedthe serum levels of COMP, IL-1 beta, CRP, and HSp70Time frame: Levels of COMP, IL-1 beta, CRP, and HSp70 will be measured one day before the start of the balneotherapy (baseline) and one day after completing the 15-session therapy (15 days) → It will be measured one day before the start of the balneotherapy (baseline) and one day after completing the 15-session therapy (15 days).
    • Addedthe serum levels of IL-1 BetaTime frame: It will be measured one day before the start of the balneotherapy (baseline) and one day after completing the 15-session therapy (15 days)
    • Addedthe serum levels of HSp70Time frame: It will be measured one day before the start of the balneotherapy (baseline) and one day after completing the 15-session therapy (15 days)
    • Addedthe serum levels of CRPTime frame: It will be measured one day before the start of the balneotherapy (baseline) and one day after completing the 15-session therapy
    Secondary outcomes 3 edited
    What changed in the outcomes
    • EditedFunctional status assessed by Western Ontario veand McMaster Universities OsteoartritOsteoarthritis Index (WOMAC)Time frame: Assessments will be made at baseline and at the end of treatment (15 season ) completion (15 days) for both groups.
    • ChangedBefore Visual Analogue ScaleNow Pain intensity assessed by Visual Analog Scale (VAS)Time frame: Assessments will be made at baseline and at the end of treatment (15 season ) completion (15 days) for both groups.
    • ChangedBefore Short -Form 36Now Health-related quality of life assessed by Short Form-36 (SF-36)Time frame: Assessments will be made at baseline and at the end of treatment (15 season ) completion (15 days) for both groups.
    + 3 other changes: verification date, registry dates and responsible party

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07008937
Lead sponsor
Ahi Evran University Education and Research Hospital
Responsible party
Figen Tuncay (Professor MD, Ahi Evran University Education and Research Hospital) — Principal investigator
First posted
Jun 6, 2025
Start date
Nov 1, 2025
Primary completion
Jul 1, 2026
Completion
Nov 30, 2026 (estimated)
Last update
Nov 9, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion